SCHEMBL27197260

SCHEMBL27197260

c1ccc(-c2cc3cnc(NC4CCOCC4)cc3[nH]2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.46
FYN P06241 1/20 0.45
CCNT1 O60563 2/20 0.44
MAPK1 P28482 3/20 0.41
MAPK3 P27361 1/20 0.40
CCNE1 P24864 4/20 0.39
CDK2 P24941 4/20 0.39
SSTR3 P32745 1/20 0.39
KCNH2 Q12809 1/20 0.39
AOC3 Q16853 1/20 0.39
TGFBR1 P36897 1/20 0.39
GPR39 O43194 1/20 0.39
CSF1R P07333 1/20 0.39
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
PRKD1 Q15139 1/20 0.38
PRKD2 Q9BZL6 1/20 0.38
CCNB2 O95067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27196893 0.85 KDM4E (0.43) LRRK2MAPK1CCNE1CDK2AOC3
SCHEMBL29776233 0.83 MAPK1 (0.44) LRRK2CCNT1MAPK1CCNE1CDK2
SCHEMBL24605550 0.83 MAPK1 (0.44) LRRK2CCNT1MAPK1CCNE1CDK2
SCHEMBL29776470 0.82 MAPK1 (0.42) LRRK2FYNMAPK1CDK2PRKD1
SCHEMBL24605565 0.82 MAPK1 (0.42) LRRK2FYNMAPK1CDK2PRKD1
SCHEMBL29776557 0.82 FYN (0.47) FYNCCNE1CDK2AOC3CSF1R
SCHEMBL24605450 0.82 FYN (0.47) FYNCCNE1CDK2AOC3CSF1R
SCHEMBL24605523 0.81 RIPK2 (0.52) FYNCCNT1MAPK1MAPK3CCNE1
SCHEMBL29776506 0.81 RIPK2 (0.52) FYNCCNT1MAPK1MAPK3CCNE1
SCHEMBL27196989 0.81 CYP19A1 (0.47) FYNCCNE1CDK2SSTR3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124444-A1 Heterocyclic Compounds and Their Use for Parasitic Diseases CELGENE CORPORATION (US) 2024-04-18 US claimed
CN-116685318-A Heterocyclic compounds and their use for parasitic diseases 细胞基因公司 2023-09-01 CN claimed
US-20240124444-A1 Heterocyclic Compounds and Their Use for Parasitic Diseases CELGENE CORPORATION (US) 2024-04-18 US disclosed
CN-116685318-A Heterocyclic compounds and their use for parasitic diseases 细胞基因公司 2023-09-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124444-A1 Heterocyclic Compounds and Their Use for Parasitic Diseases CYP11B2, CYP11B1, CYP8B1 LRRK2 1518/4885FYN 2349/4885CCNT1 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.